ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2020

The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.

Alberto Mazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.